{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:36:55Z","timestamp":1793284615561,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772138"],"award-info":[{"award-number":["2025M772138"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370482"],"award-info":[{"award-number":["82370482"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270346"],"award-info":[{"award-number":["82270346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301368"],"award-info":[{"award-number":["82301368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.hrtlng.2026.102943","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:29:22Z","timestamp":1789100962000},"page":"102943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Glucagon-like peptide-1 receptor activation, inflammation and heart failure: Insights from genetic analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Yuhuan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6539-0797","authenticated-orcid":false,"given":"Wenxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hrtlng.2026.102943_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027852","article-title":"Burden, trends, and inequalities of heart failure globally, 1990 to 2019: a secondary analysis based on the global Burden of disease 2019 study","volume":"12","author":"Yan","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.hrtlng.2026.102943_bib0002","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"10437","key":"10.1016\/j.hrtlng.2026.102943_bib0003","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2024.04.022","article-title":"Semaglutide and NT-proBNP in obesity-related HFpEF: insights from the STEP-HFpEF program","volume":"84","author":"Petrie","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.hrtlng.2026.102943_bib0005","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2024.08.021","article-title":"Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure","volume":"84","author":"Solomon","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"10454","key":"10.1016\/j.hrtlng.2026.102943_bib0006","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.hrtlng.2026.102943_bib0007","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2024.08.004","article-title":"Effects of semaglutide on heart failure outcomes in diabetes and chronic kidney disease in the FLOW trial","volume":"84","author":"Pratley","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hrtlng.2026.102943_bib0008","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"19","key":"10.1016\/j.hrtlng.2026.102943_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031786","article-title":"Connecting the dots: inflammatory burden and outcomes in heart failure","volume":"12","author":"Golino","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102943_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102943_bib0011","article-title":"Pathogenic pathways and therapeutic targets of inflammation in heart diseases: a focus on Interleukin-1","volume":"54","author":"Del Buono","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.hrtlng.2026.102943_bib0012","first-page":"1","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"8","key":"10.1016\/j.hrtlng.2026.102943_bib0013","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.hrtlng.2026.102943_bib0014","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s10787-024-01556-2","article-title":"Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications","volume":"32","author":"Satheesan","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"19","key":"10.1016\/j.hrtlng.2026.102943_bib0015","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.hrtlng.2026.102943_bib0016","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.hrtlng.2026.102943_bib0017","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.hrtlng.2026.102943_bib0018","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.hrtlng.2026.102943_bib0019","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Jr. Inflammation in Heart failure: JACC State-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0020","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/s41467-022-29650-5","article-title":"Genetic analysis of over half a million people characterises C-reactive protein loci","volume":"13","author":"Said","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102943_bib0022","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/oby.23060","article-title":"The role of inflammatory cytokines as intermediates in the pathway from increased adiposity to disease","volume":"29","author":"Kalaoja","year":"2021","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0023","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1038\/s41467-020-19996-z","article-title":"Genetic architecture of host proteins involved in SARS-CoV-2 infection","volume":"11","author":"Pietzner","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.hrtlng.2026.102943_bib0024","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals","volume":"2","author":"Folkersen","year":"2020","journal-title":"Nat Metab"},{"issue":"7944","key":"10.1016\/j.hrtlng.2026.102943_bib0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.hrtlng.2026.102943_bib0026","first-page":"175","volume":"139","author":"Michael","year":"2011"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0027","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pharep.2017.10.003","article-title":"Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway","volume":"70","author":"Gallego-Colon","year":"2018","journal-title":"Pharmacol Rep"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102943_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12317","article-title":"Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor \u03b1-mediated activation","volume":"36","author":"Garczorz","year":"2018","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102943_bib0029","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/abbs\/gmy177","article-title":"Liraglutide alleviates cardiac fibrosis through inhibiting P4h\u03b1-1 expression in STZ-induced diabetic cardiomyopathy","volume":"51","author":"Zhao","year":"2019","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"11","key":"10.1016\/j.hrtlng.2026.102943_bib0030","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00011-024-01950-0","article-title":"Cyclic adenosine monophosphate critically modulates cardiac GLP-1 receptor's anti-inflammatory effects","volume":"73","author":"Stoicovy","year":"2024","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-41954-w","article-title":"Semaglutide restores metabolic and structural homeostasis along the gut-heart-metabolic axis in a cafeteria diet-induced obesity model","volume":"16","author":"Doganay","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0032","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCRESAHA.120.317685","article-title":"Multiscale analysis of extracellular matrix remodeling in the failing heart","volume":"128","author":"Perestrelo","year":"2021","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.hrtlng.2026.102943_bib0033","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1172\/JCI8040","article-title":"Disruption of the myocardial extracellular matrix leads to cardiac dysfunction","volume":"106","author":"Kim","year":"2000","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102943_bib0034","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/cvr\/cvn235","article-title":"Biochemical markers of myocardial remodelling in hypertensive heart disease","volume":"81","author":"Gonz\u00e1lez","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.hrtlng.2026.102943_bib0035","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2004.07.023","article-title":"Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression","volume":"44","author":"Polyakova","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hrtlng.2026.102943_bib0036","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/ejhf.3264","article-title":"Mechanisms of myocardial reverse remodelling and its clinical significance: a scientific statement of the ESC Working Group on Myocardial Function","volume":"26","author":"Falc\u00e3o-Pires","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.hrtlng.2026.102943_bib0037","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.3390\/cimb46080500","article-title":"Diagnostic and prognostic role of circulating microRNAs in patients with coronary artery disease\u2014Impact on left ventricle and arterial function","volume":"46","author":"Iacobescu","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"10.1016\/j.hrtlng.2026.102943_bib0038","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/jocs.16449","article-title":"Role of matrix metalloproteinases in mitral valve regurgitation: association between the of MMP-1, MMP-9, TIMP-1, and TIMP-2 expression, degree of mitral valve insufficiency, and pathologic etiology","volume":"37","author":"Irqsusi","year":"2022","journal-title":"J Card Surg"},{"issue":"5","key":"10.1016\/j.hrtlng.2026.102943_bib0039","doi-asserted-by":"crossref","first-page":"H1269","DOI":"10.1152\/ajpheart.00099.2018","article-title":"Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents","volume":"315","author":"Corporan","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-8-50","article-title":"MMP-1 serum levels predict coronary atherosclerosis in humans","volume":"8","author":"Lehrke","year":"2009","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.hrtlng.2026.102943_bib0041","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.3390\/ijms24119129","article-title":"Abdel-Latif A. C-reactive protein levels and risk of cardiovascular diseases: a two-sample bidirectional mendelian randomization study","volume":"24","author":"Kuppa","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102943_bib0042","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2006.02.055","article-title":"Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial","volume":"48","author":"Hudson","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102943_bib0043","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jacbts.2024.11.009","article-title":"Shear-thinning hydrogel for delayed delivery of a small molecule metalloproteinase inhibitor attenuates myocardial infarction remodeling","volume":"10","author":"Mealy","year":"2025","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102943_bib0044","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/biom15040598","article-title":"Matrix metalloproteinases: pathophysiologic implications and potential therapeutic targets in cardiovascular disease","volume":"15","author":"Tanase","year":"2025","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102943_bib0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014795632600227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014795632600227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:11:18Z","timestamp":1793283078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014795632600227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S014795632600227X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102943","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor activation, inflammation and heart failure: Insights from genetic analysis","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102943"}}